Public Sector Pension Investment Board (PSP Investments)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22.7M Buy
669,567
+54,100
+9% +$1.8M 0.06% 269
2026
Q1
$18.5M Buy
615,467
+37,100
+6% +$1.19M 0.06% 277
2025
Q4
$18.1M Sell
578,367
-92,100
-14% -$2.27M 0.06% 237
2025
Q3
$13.5M Buy
670,467
+69,000
+11% +$1.21M 0.05% 333
2025
Q2
$10.1M Buy
601,467
+14,300
+2% +$231K 0.04% 376
2025
Q1
$9.02M Buy
587,167
+38,400
+7% +$686K 0.04% 424
2024
Q4
$12.1M Sell
548,767
-32,200
-6% -$586K 0.05% 271
2024
Q3
$10.5M Buy
580,967
+110,300
+23% +$1.93M 0.06% 197
2024
Q2
$7.65M Buy
470,667
+25,718
+6% +$396K 0.05% 250
2024
Q1
$6.28M Buy
444,949
+43,641
+11% +$550K 0.05% 291
2023
Q4
$4.19M Buy
401,308
+1,800
+0.5% +$16.8K 0.03% 431
2023
Q3
$4.07M Buy
399,508
+6,200
+2% +$57.7K 0.03% 400
2023
Q2
$2.96M Hold
393,308
0.02% 696
2023
Q1
$3.48M Buy
393,308
+9,600
+3% +$94.9K 0.03% 600
2022
Q4
$3.5M Buy
383,708
+53,520
+16% +$467K 0.03% 601
2022
Q3
$2.67M Buy
330,188
+5,100
+2% +$45.1K 0.02% 668
2022
Q2
$2.44M Hold
325,088
0.02% 699
2022
Q1
$3.05M Hold
325,088
0.02% 753
2021
Q4
$2.6M Buy
325,088
+3,700
+1% +$33.4K 0.01% 957
2021
Q3
$3.13M Sell
321,388
-12,200
-4% -$114K 0.02% 845
2021
Q2
$3.3M Buy
333,588
+2,000
+0.6% +$21.2K 0.02% 814
2021
Q1
$3.83M Sell
331,588
-30,100
-8% -$345K 0.02% 622
2020
Q4
$3.49M Sell
361,688
-6,500
-2% -$62.3K 0.03% 614
2020
Q3
$3.32M Buy
368,188
+2,900
+0.8% +$30.7K 0.03% 606
2020
Q2
$4.5M Buy
365,288
+1,900
+0.5% +$21.5K 0.04% 415
2020
Q1
$3.26M Sell
363,388
-9,301
-2% -$95.3K 0.04% 421
2019
Q4
$3.65M Sell
372,689
-21,613
-5% -$193K 0.02% 782
2019
Q3
$2.71M Buy
394,302
+66,378
+20% +$509K 0.02% 885
2019
Q2
$3.03M Buy
327,924
+126,176
+63% +$1.52M 0.02% 695
2019
Q1
$3.16M Buy
201,748
+5,011
+3% +$88.4K 0.03% 469
2018
Q4
$3.03M Buy
196,737
+10,677
+6% +$219K 0.03% 457
2018
Q3
$4.01M Sell
186,060
-5,237
-3% -$122K 0.03% 403
2018
Q2
$4.65M Sell
191,297
-3,569
-2% -$72.8K 0.03% 331
2018
Q1
$3.33M Sell
194,866
-5,405
-3% -$106K 0.02% 330
2017
Q4
$3.79M Hold
200,271
0.02% 393
2017
Q3
$3.52M Hold
200,271
0.02% 392
2017
Q2
$6.65M Buy
200,271
+2,391
+1% +$74K 0.06% 262
2017
Q1
$6.35M Sell
197,880
-495,543
-71% -$16.9M 0.06% 328
2016
Q4
$25.1M Buy
693,423
+4,963
+0.7% +$198K 0.25% 88
2016
Q3
$31.7M Hold
688,460
0.33% 63
2016
Q2
$34.6M Hold
688,460
0.38% 49
2016
Q1
$36.8M Hold
688,460
0.41% 45
2015
Q4
$45.2M Hold
688,460
0.37% 50
2015
Q3
$38.9M Buy
688,460
+100,000
+17% +$6.48M 0.35% 60
2015
Q2
$34.8M Hold
588,460
0.25% 89
2015
Q1
$36.7M Hold
588,460
0.27% 84
2014
Q4
$33.8M Hold
588,460
0.22% 103
2014
Q3
$31.6M Hold
588,460
0.21% 109
2014
Q2
$30.8M Hold
588,460
0.19% 115
2014
Q1
$31.1M Buy
588,460
+58,000
+11% +$2.68M 0.2% 104
2013
Q4
$21.3M Hold
530,460
0.13% 148
2013
Q3
$20M Hold
530,460
0.12% 146
2013
Q2
$20.8M Buy
+530,460
New +$20.7M 0.16% 125

Other funds holding TEVA

Public Sector Pension Investment Board (PSP Investments)'s TEVA Position: Q2 2026 in Review

Public Sector Pension Investment Board (PSP Investments) increased its Teva Pharmaceuticals (TEVA) stake by 8.8% in Q2 2026, buying an estimated $1.8M and bringing the position to 669,567 shares worth $22.7M. The position accounts for 0.06% of the portfolio, ranked #269.

Public Sector Pension Investment Board (PSP Investments) first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $45.2M in Q4 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 669,567 shares of Teva Pharmaceuticals worth $22.7M as of Q2 2026.
  • Public Sector Pension Investment Board (PSP Investments) bought 54,100 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.8M.
  • Teva Pharmaceuticals made up 0.06% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q2 2026, its #269 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Public Sector Pension Investment Board (PSP Investments)'s Teva Pharmaceuticals position peaked at $45.2M in Q4 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.